Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;

Risultato della ricerca: Paper

Abstract

No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
Lingua originaleEnglish
Stato di pubblicazionePublished - 2012

Fingerprint

Factor VII Deficiency
Registries
Economics
Guidelines
Safety
Therapeutics

Cita questo

Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J; (2012). Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER. / Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;.

2012.

Risultato della ricerca: Paper

Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J; 2012, 'Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER'.
Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;. Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER. 2012.
Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;. / Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.
@conference{6dc5bfe7ca9a43bf8f054eab974fd0cb,
title = "Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER",
abstract = "No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).",
keywords = "Adverse Events, Inherited Fasctor VII deficiency",
author = "{Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda L{\'o}pez, Mf; Ruiz De Saez, A; Ingerslev, J;} and Sergio Siragusa and Mariasanta Napolitano",
year = "2012",
language = "English",

}

TY - CONF

T1 - Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

AU - Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;

AU - Siragusa, Sergio

AU - Napolitano, Mariasanta

PY - 2012

Y1 - 2012

N2 - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).

AB - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).

KW - Adverse Events, Inherited Fasctor VII deficiency

UR - http://hdl.handle.net/10447/76370

M3 - Paper

ER -